Ankylosing spondylitis En

Fiche du sujet

Référentiel
Identifiant

Synonyme

Spondylarthritis ankylopoietica Marie-Strümpell spondylitis Bekhterev's disease Rheumatoid spondylitis Marie-Struempell disease Spondylitis ankylopoietica Bechterew's disease

Discipline

Psychologie (4) Histoire (4) Philosophie (1) Education (1)

Type de document

Articles (16) Recensions (2) Mémoires, Thèses et HDR (1) Autres (1) Jeux de données (1) Colloques et conférences (1)

Auteur

Date

20 documents
Secukinumab demonstrated sustained retention, effectiveness and safety in a real-world setting in patients with moderate-to-severe plaque psoriasis: long-term results from an interim analysis of the SERENA study.
M. Augustin et al.
Both disease activity and HLA-B27 determine gut microbiome dysbiosis in spondyloarthritis
Magali Berland et al. (28 sept. 2022)
TNF-α inhibitor-induced paradoxical psoriasis and erythema nodosum in a patient with ankylosing spondylitis
Daisuke Watabe et al. (2021)
Spondyloarthritis-Associated IgA Nephropathy
N. Champtiaux et al.
Inflammasomes contributing to inflammation in arthritis.
L. Spel et al.
Strategies for the assessment of competences during rheumatology training across Europe: results of a qualitative study
Aurélie Najm et al. (2020)
L’hôpital thermal de Dax, un établissement unique en France
Richard Vento et al. (2020)
ALIGNed on adherence: subanalysis of adherence in immune-mediated inflammatory diseases in the DACH region of the global ALIGN study.
AGA Kolios et al.
TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort.
C. Molnar et al.
Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis.
R. Micheroli et al. (19 juil. 2017)
Is it possible to predict which patients treated with biologic agents for rheumatic diseases will develop anti-drug antibodies?
M. FAVRE-DIT-JEANFAVRE (2016)
Extraintestinal Manifestations of Inflammatory Bowel Disease.
S.R. Vavricka et al. (2015)
Long-term safety and efficacy of etanercept in the treatment of ankylosing spondylitis
J. M. Senabre et al. (11 nov. 2014)
Evaluation of anti-tumor necrosis factor levels and anti-tumor necrosis factor antibodies in rheumatic diseases treated with infliximab and adalimumab; preliminary results from a local registry.
J. Rosas et al. (4 nov. 2014)
Duración del tratamiento con etanercept y razones de discontinuación en una cohorte de pacientes con patología reumática
J. M. Senabre et al. (4 nov. 2014)
Características de los pacientes tratados con Etanercept de un registro local de terapia biológica
J. Rosas et al. (4 nov. 2014)
Enfermedad crónica: satisfacción vital y estilos de personalidad adaptativos
María José Sánchez Elena et al. (2014)
Insalubridad en el hogar durante la infancia de pacientes mestizos mexicanos con espondilitis anquilosante y artritis reumatoide
F. Javier Jimenez-Balderas et al. (2008)
Parasitosis intestinal extrema en la infancia previa al desarrollo de enfermedades reumáticas inflamatorias/autoinmunes
F. Javier Jiménez-Balderas et al. (2008)
Sur quelques aspects insolites de la radiologie de Ramsès II
Roger Lichtenberg et al. (1981)